RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Angiosarcoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Pleural Metastasis in Epithelioid Angiosarcoma
Martha Milena Alfonso Gamba et al., Cureus (18 October 2026)
https://doi.org/10.7759/cureus.118090
- 2.
Genomic and Transcriptomic Characterization of Angiosarcomas: Focus on Cardiac Origin.
Lu Tao et al., Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42874741/
- 3.
Unresectable extremity angiosarcoma with bone marrow involvement and Kasabach-Merritt-like consumptive coagulopathy.
Yamada Hideharu et al., BMJ case reports (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42869573/
- 4.
Primary Breast Angiosarcoma: Clinicopathologic Features and Oncologic Outcomes.
Vavolizza Rick D et al., Annals of surgical oncology (12 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42864567/
- 5.
MYC drives endothelial transformation and dedifferentiation in angiosarcoma
Chen Khuan Wong et al., bioRxiv (Cold Spring Harbor Laboratory) (9 October 2026)
https://doi.org/10.64898/2026.10.07.757149
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
NCT00346164 · Completed · Phase 3 · Children's Oncology Group
Up to age 29
https://clinicaltrials.gov/study/NCT00346164
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Angiosarcoma
Angiosarcoma is a rare cancer that starts in the cells lining blood vessels or lymphatic vessels. It can arise in the skin, particularly of the scalp and face, or in deeper organs such as the breast, liver, heart and spleen. Treatment usually involves surgery, often with radiotherapy and chemotherapy, and research into new therapies is ongoing.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Angiosarcoma?
Angiosarcoma is a rare cancer that starts in the cells lining blood vessels or lymphatic vessels. It can arise in the skin, particularly of the scalp and face, or in deeper organs such as the breast, liver, heart and spleen. Treatment usually involves surgery, often with radiotherapy and chemotherapy, and research into new therapies is ongoing.
How many clinical trials are available for Angiosarcoma?
RareWays currently indexes 58 clinical trials for Angiosarcoma, of which 12 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Angiosarcoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Angiosarcoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.